Cara Therapeutics (NASDAQ:CARA) reported its Q3 earnings results on Monday, November 13, 2023 at 04:01 PM.
Here’s what investors need to know about the announcement.
Earnings
Cara Therapeutics reported in-line EPS of $-0.52 versus an estimate of $-0.52.
Revenue was down $5.95 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.02 which was followed by a 0.34% drop in the share price the next day.
Here’s a look at Cara Therapeutics’s past performance:
| Quarter | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.56 | -0.52 | -0.32 | -0.42 |
| EPS Actual | -0.58 | -0.49 | -0.56 | -0.43 |
| Revenue Estimate | 6.49M | 4.98M | 16.25M | 9.83M |
| Revenue Actual | 6.93M | 6.17M | 3.26M | 10.81M |
To track all earnings releases for Cara Therapeutics visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
